Capecitabine Added To Standard Treatment Given Before Surgery Helps To Eradicate Tumo

[News]

Data from the ABCSG-24 study presented at the joint 15th ECCO and 34th ESMO congress in Berlin, Germany, show that adding capecitabine (Xeloda(R)) to anthracycline- and taxane-containing regimens prior to surgery (neoadjuvant therapy) completely eradicated the tumour in 24% of women with HER2-positive or HER2-negative early breast cancer.

More... (http://www.medicalnewstoday.com/articles/165014.php)